NCT06614582
Long-term Evaluation of Nasopharyngeal Airway in Hypotonia
StatusEnrolling by Invitation
PhaseNot applicable
SponsorUniversity of Michigan
Primary completion (estimated)
At risk: Primary completion moved at least 1 year 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Oct 2026 to Oct 2028 Show 4 more changesShow less
- Eligibility criteria expanded, about 12 words
- Primary endpoints: details revised at 1 of 2 entries
- Secondary endpoints: details revised at 3 of 4 entries
- Publications: details revised at 1 of 1 entry
- Minor Start date changed from estimate of Oct 2024 to Oct 23, 2024v3
- Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
- Site contact updated
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Obstructive sleep apnea (OSA) severity measured by the apnea/hypopnea index (AHI) assessed by overnight polysomnography
Timeframe: Approximately 1 year
Long term device tolerability assessed by self-report from caregivers
Timeframe: 2 years
Secondary (4)
Long-term impact on sleep quality will be assessed by the mean score on the parent report of sleep quality
Long-term impact on daytime sleepiness will be assessed by the mean score on the children's Epworth Sleepiness Scale (ESS)
Long-term impact on quality of life will be assessed with the OSA-18
Family Impact Questionnaire (FIQ)
Arms and interventions
Self-Supporting Nasopharyngeal Airway (ssNPA)Experimental
Participants will use the device up to 24 months.
Devices: Self-Supporting Nasopharyngeal Airway (ssNPA)
Sites
1 site in 1 country
- University of MichiganAnn Arbor, Michigan, United States